Intuitive Surgical (NASDAQ:ISRG) Price Target Lowered to $550.00 at JPMorgan Chase & Co.

Intuitive Surgical (NASDAQ:ISRG) had its price target lowered by JPMorgan Chase & Co. from $625.00 to $550.00 in a report issued on Wednesday,MarketScreener reports. The firm currently has an overweight rating on the medical equipment provider’s stock.

A number of other equities analysts also recently issued reports on ISRG. Evercore lowered their price target on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research report on Monday, April 6th. HSBC increased their price target on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research report on Monday, January 26th. The Goldman Sachs Group lowered their price target on Intuitive Surgical from $714.00 to $609.00 and set a “buy” rating on the stock in a research report on Wednesday, April 8th. Robert W. Baird lowered their price target on Intuitive Surgical from $645.00 to $575.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 15th. Finally, Sanford C. Bernstein raised their target price on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. Eighteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $586.70.

Intuitive Surgical Trading Up 7.2%

Shares of ISRG stock opened at $483.62 on Wednesday. The company has a market capitalization of $171.75 billion, a P/E ratio of 58.62, a P/E/G ratio of 3.52 and a beta of 1.68. The business’s 50 day moving average is $477.54 and its two-hundred day moving average is $515.41. Intuitive Surgical has a 12-month low of $427.84 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.96% and a net margin of 28.15%.Intuitive Surgical’s revenue for the quarter was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.81 earnings per share. On average, research analysts predict that Intuitive Surgical will post 8.16 earnings per share for the current fiscal year.

Insider Activity

In related news, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Gary S. Guthart sold 24,500 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the transaction, the director owned 3,694 shares in the company, valued at approximately $1,958,189.40. The trade was a 86.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 32,943 shares of company stock valued at $17,279,568 in the last 90 days. 0.60% of the stock is owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors have recently added to or reduced their stakes in ISRG. Brighton Jones LLC lifted its position in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares in the last quarter. Sivia Capital Partners LLC raised its position in Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after purchasing an additional 34 shares during the period. Schnieders Capital Management LLC. raised its position in Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after purchasing an additional 268 shares during the period. Osterweis Capital Management Inc. purchased a new stake in Intuitive Surgical in the second quarter valued at $200,000. Finally, Main Street Financial Solutions LLC raised its position in Intuitive Surgical by 92.4% in the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock valued at $1,592,000 after purchasing an additional 1,407 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat on top and bottom lines — Intuitive reported $2.50 non‑GAAP EPS vs. ~$2.08 expected and $2.77B revenue (≈23% YoY), which drove the immediate market rally. ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
• Positive Sentiment: Procedure growth is the operational driver — combined da Vinci and Ion procedures grew meaningfully (da Vinci ≈16% and Ion ≈39% in Q1), supporting recurring consumables and service revenue. Intuitive Announces First Quarter Earnings
• Positive Sentiment: Company raised full‑year/procedure guidance — management modestly lifted its procedure-growth outlook for 2026, which investors read as validation that demand is holding. Intuitive Surgical Jumps 7% on Earnings Beat and Raised Full-Year Outlook
• Neutral Sentiment: Analyst reactions are mixed but active — several firms raised targets or reiterated Buys (Goldman, Baird), while others trimmed targets; net impact is more analyst attention and updated model assumptions. Analysts Boost Forecasts After Upbeat Q1
• Neutral Sentiment: Market volatility around the print — shares initially moved in after‑hours trading and then again on the next session as investors parsed the beat vs. the tone of guidance. Reuters: Intuitive Beats Quarterly Expectations
• Negative Sentiment: Guidance viewed as conservative by some — a few investors and writers note the raise was smaller than the quarter’s beat, and management flagged international headwinds; that tempers expectations for sustained upside. Why Robotics Giant Intuitive Surgical Dropped Despite Its Beat And Raise

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.